Our Vision

Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.

What We Do

We help the cancer community push the field of routine cancer care forward in the following ways:

Patients first. We bring a pan-cancer orientation to the treatment of both solid tumors and hematologic cancers, and help make precision medicine a reality for patients by providing comprehensive genomic profiles to oncologists to help them match their patients to targeted therapies.

Research. We collaborate with drug developers and cancer researchers to identify novel targets and assist in the development of targeted cancer therapies and active clinical trials.

Data. We leverage our molecular information platform, using our growing knowledgebase of genomic information about human cancers and incorporating clinical data, to inform drug development and enable precision medicine.

Our Expertise

We are a passionate group of experts in genome technology, cancer biology, clinical oncology and information science. We are also supported by leaders in business development and commercialization.

Working together, we turn our proven science into commercial products that are rapidly becoming a trusted and routine component of cancer care.

Learn more about our expertise

Our Breakthroughs

Both FoundationOne® and FoundationOne® Heme reveal the alterations that are driving the growth of a patient’s cancer. This information helps physicians to precisely and confidently identify targeted treatment options that may not have been otherwise considered.

FoundationOne and FoundationOne Heme comprehensively and accurately analyze all genes known to be relevant in human cancers, and find all classes of alterations in these genes that may be contributing to a tumor’s growth.

The field is moving rapidly, and new data becomes available almost daily. Our analysis is informed by the latest information available. We provide physicians with concise, yet detailed, user-friendly reports that clearly explain their patients’ genomic alterations and help match them with the available targeted therapies and clinical trials.

Our molecular information platform continues to grow with every test we run, whether for pharmaceutical or for clinical use. This data can be used to continually improve our understanding of cancer and even find new ways to control its growth.

Making an Impact

We’ve made a difference in the lives of thousands of patients already. But, there’s more work to be done.

Our impact so far:

  • More than 10,000 patients tested with FoundationOne® or FoundationOne® Heme
  • 2 clinical tests on the market
  • 315 cancer-related genes assessed by FoundationOne
  • 405 cancer-related genes assessed by FoundationOne Heme
  • 22 peer-reviewed papers published in 2013
  • More than 15 pharma industry partners

Learn more about our impact

How We Do It

Serving one patient not only helps that patient, but ultimately serves all of the patients that follow, involving every cancer patient in the transformation of cancer care.

Clinical Products

We provide two best-in-class genomic tests for patients—FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies, sarcomas, and pediatric cancers. These assays have undergone robust analytic validation and have been proven to be among the most accurate, sensitive, and comprehensive tests available today—which means more options for patient care.

Our test results combine the molecular information from our assays with up-to-date information on the latest scientific and clinical data. We distill this into easy-to-read reports with the most actionable information to help inform patient treatment. We also offer additional materials, services, and real-time data through our technology products, like our Interactive Cancer Explorer™.

Technology Products & Services

We are creating a dynamic network of users generating valuable information—perhaps the largest database of cancer molecular information in the world, that is easily accessible and can be shared across the cancer community.

Physicians, drug developers, cancer researchers and patient advocates leverage our molecular information platform every day because we connect the dots between real-time patient results, existing therapies and the latest research. Through our products and services, like our Interactive Cancer Explorer, the oncology community has access to genomic and clinical data, advanced analytics and published peer-reviewed research to aid them in treatment decisions and therapy development.

Pharma Research Collaborations

The molecular information we generate helps drug developers and clinical researchers create newer and better therapies today.

Currently, we collaborate with more than 15 biotech and pharmaceutical companies to help accelerate the development of new targeted therapies.

Our molecular information platform enables these companies to more quickly select the promising drug candidates and to identify genomic signatures and mechanisms of sensitivity or resistance. In turn, this information is used to design more efficient clinical trials to accelerate the delivery of safe, effective targeted therapies for patients with cancer.

Why We Do It

Our goal to transform cancer care is driven by our passion to help patients as well as our personal connections to people impacted by cancer.

Learn more about our culture

Who We Are

Our employees are the true foundation of the company. They bring passion, dedication and curiosity that continuously propel us to the leading edge in the transformation in cancer care.

I am most proud of the hard work that everyone at Foundation Medicine has done to provide the best possible molecular testing for cancer patients.
Garrett Frampton, PhD Senior Bioinformatics Scientist

The vision we share as a company is so important, because it keeps the patient at the forefront of everything we do.
Lazaro Garcia, MPH Manager, Clinical laboratory

We are making new discoveries about what drives cancer, and identifying potential therapeutic targets.
Juliann Chmielecki, PhD Senior Scientist II, Cancer Genomics

Knowing that we are directly changing how patients are treated and giving them a more comprehensive view of their disease is what is the most exciting and motivating for me.
Caitlin McMahon Clinical Bioinformatics Analyst

Everyone is driven by a desire to alleviate the suffering of cancer patients and find the best possible options for their treatment.
Rachel Erlich, PhD Director, Biomedical Informatics

I work with an amazing group of individuals both in my department and outside. At the end of the day, we all care about patients receiving the best treatment options available for them.
Anthony Burris Client Services Representative

You dream of what you’re going to do as a kid. If you have a dream of doing something significant in medicine, you’re actually realizing your childhood dream at Foundation Medicine and that’s an opportunity I never really expected to have.
Julia Elvin, MD, PhD Senior Pathologist

We all work together to overcome challenges one by one, and we respect, support, and learn from each other!
Kai Wang, MD, PhD Senior Scientist

Whether it is a personal loss or battle of a loved one, or a need to save the world, you won’t find anyone here who isn’t motivated by the mission of this company. Everyone here sees a patient as a person, not a number.
Bati Katzman Clinical Genomic Analyst

Foundation Medicine is special because of the ridiculously smart people who work here, which makes every day extremely humbling, and the huge sense of responsibility to get it right—because it is patients’ lives we are dealing with.
Khaled Habayeb Director, Investor Relations

It makes me really proud to know how high Foundation Medicine ranks in all these work surveys that we do. I believe it’s a testament to the amazing work culture we have.
Jennifer Bun Supervisor, Client Services

We have the unique ability to impact the lives of cancer patients every day. This is truly a humbling role that we’re reminded of when we realize that each sample going through the lab is a patient that we might be able to help.
Matthew Hawryluk, PhD Senior Director, Business Development

Learn more about job opportunities